These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 730366)
21. The effect of prostaglandin E2 on the initial immune response to herpes simplex virus infection. Baker DA; Thomas J Am J Obstet Gynecol; 1985 Mar; 151(5):586-90. PubMed ID: 3872073 [TBL] [Abstract][Full Text] [Related]
23. [Evaluation of the immune and interferon status of children infected with herpes simplex virus and living in areas with increased radiation background]. Alimbarova LM; Sokha LG; Baleva LS; Lavrukhina LA; Barinskiĭ IF Vopr Virusol; 1997; 42(1):36-41. PubMed ID: 9103044 [TBL] [Abstract][Full Text] [Related]
24. Herpes simplex of the nipple: infant-to-mother transmission. Sealander JY; Kerr CP Am Fam Physician; 1989 Mar; 39(3):111-3. PubMed ID: 2923026 [TBL] [Abstract][Full Text] [Related]
25. Nonvirion antigens produced by herpes simplex viruses 1 and 2. Tarro G; Sabin AB Proc Natl Acad Sci U S A; 1973 Apr; 70(4):1032-6. PubMed ID: 4352219 [TBL] [Abstract][Full Text] [Related]
26. [Herpetic infection of the oral cavity in guinea pigs]. Antonova NI Vopr Virusol; 1977; (1):92-5. PubMed ID: 198963 [TBL] [Abstract][Full Text] [Related]
27. Comparison of the humoral and cellular immune response after immunization with live, UV inactivated herpes simplex virus and a subunit vaccine and efficacy of these immunizations. Cappel R Arch Virol; 1976; 52(1-2):29-35. PubMed ID: 187150 [TBL] [Abstract][Full Text] [Related]
28. Detection of type-specific antibody to herpes simplex virus type 1 and 2 in human sera by complement-fixation tests. Skinner GR; Hartley CH; Whitney JE Arch Virol; 1976; 50(4):323-33. PubMed ID: 179502 [TBL] [Abstract][Full Text] [Related]
29. Immune response to a DNA free herpes simplex vaccine in man. Cappel R; Sprecher S; Rickaert F; de Cuyper F Arch Virol; 1982; 73(1):61-7. PubMed ID: 6289778 [TBL] [Abstract][Full Text] [Related]
30. [Specific and unspecific immune stimulation in recurrent herpes simplex]. Raab W Z Hautkr; 1977 May; 52(10):565-72. PubMed ID: 195407 [TBL] [Abstract][Full Text] [Related]
31. Cell-mediated immune responses in patients with recurrent Herpes Simplex infections. II. Infection-associated deficiency of lymphokine production in patients with recurrent herpes labialis or herpes progenitalis. O'Reilly RJ; Chibbaro A; Anger E; Lopez C J Immunol; 1977 Mar; 118(3):1095-1102. PubMed ID: 191524 [TBL] [Abstract][Full Text] [Related]
32. Specific IgG and IgM antibody responses in herpes-simplex-virus infections. Kurtz JB J Med Microbiol; 1974 Aug; 7(3):333-41. PubMed ID: 4213974 [No Abstract] [Full Text] [Related]
33. Cellular immune response in genital herpes simplex virus infection. Corey L; Reeves WC; Holmes KK N Engl J Med; 1978 Nov; 299(18):986-91. PubMed ID: 211414 [TBL] [Abstract][Full Text] [Related]
34. Cell-mediated and humoral immune responses or renal transplant recipients with cytomegalovirus infections. Lopez C; Simmons RL; Park BH; Najarian JS; Good RA Clin Exp Immunol; 1974 Apr; 16(4):565-73. PubMed ID: 4377553 [TBL] [Abstract][Full Text] [Related]
35. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1. Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403 [TBL] [Abstract][Full Text] [Related]
36. Herpes simplex type 1 infections in group day care. Schmitt DL; Johnson DW; Henderson FW Pediatr Infect Dis J; 1991 Oct; 10(10):729-34. PubMed ID: 1658720 [TBL] [Abstract][Full Text] [Related]
37. Gianotti-Crosti syndrome associated with herpes simplex virus type 1 gingivostomatitis. Dauendorffer JN; Dupuy A J Am Acad Dermatol; 2011 Feb; 64(2):450-1. PubMed ID: 21238841 [No Abstract] [Full Text] [Related]
38. Interferon, antibody, and other host factors in herpes zoster. Stevens DA; Merigan TC J Clin Invest; 1972 May; 51(5):1170-8. PubMed ID: 5020430 [TBL] [Abstract][Full Text] [Related]
39. Recurrent herpes simplex virus type 1 infection precipitated by the impaired production of interleukin-2, alpha-interferon, and cell-mediated cytotoxicity. Kuo YC; Lin CY J Med Virol; 1990 Jul; 31(3):183-9. PubMed ID: 2167943 [TBL] [Abstract][Full Text] [Related]
40. Enzyme immunoassay for measurement of antibodies to herpes simplex virus infection: comparison with complement fixation, immunofluorescent-antibody, and neutralization techniques. Denoyel GA; Gaspar A; Nouyrigat C J Clin Microbiol; 1980 Feb; 11(2):114-9. PubMed ID: 6244329 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]